About the Authors

Mark T. Orr

Affiliation Department of Microbiology and Immunology and the Cancer Research Institute, University of California San Francisco, San Francisco, California, United States of America

Jun Wu

Affiliation DNAX Research Institute, Palo Alto, California, United States of America

Min Fang

Affiliation Immune Cell Development and Host Defense Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America

Luis J. Sigal

Affiliation Immune Cell Development and Host Defense Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America

Pieter Spee

Affiliation Department of NK Cell Biology, Novo Nordisk A/S, Måløv, Denmark

Thomas Egebjerg

Affiliation Department of NK Cell Biology, Novo Nordisk A/S, Måløv, Denmark

Erik Dissen

Affiliation Department of Anatomy, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway

Sigbjørn Fossum

Affiliation Department of Anatomy, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway

Joseph H. Phillips

Affiliation DNAX Research Institute, Palo Alto, California, United States of America

Lewis L. Lanier

Lewis.Lanier@ucsf.edu

Affiliation Department of Microbiology and Immunology and the Cancer Research Institute, University of California San Francisco, San Francisco, California, United States of America

Competing Interests

The authors have read the journal's policy and have the following conflicts: J.H.P. is an employee of Merck; P.S. and T.E. are employees of Novo Nordisk. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The other authors have no financial conflicts of interest.

Author Contributions

Conceived and designed the experiments: MTO JW MF LJS JHP LLL. Performed the experiments: MTO JW MF. Analyzed the data: MTO JW MF LJS JHP LLL. Contributed reagents/materials/analysis tools: PS TE ED SF. Wrote the paper: MTO LLL.